Pages that link to "Q36313089"

The following pages link to The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis (Q36313089):

Displaying 50 items.

• The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation (Q24297959) (← links)
• Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours (Q24299088) (← links)
• Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor RASSF1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cells (Q24302341) (← links)
• The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex (Q24306286) (← links)
• The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells (Q24312020) (← links)
• UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene (Q24321830) (← links)
• The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death (Q24336280) (← links)
• HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro (Q24336517) (← links)
• Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras (Q24338128) (← links)
• RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies (Q24626144) (← links)
• State of the science: an update on renal cell carcinoma (Q24630685) (← links)
• Characteristic promoter hypermethylation signatures in male germ cell tumors (Q24799928) (← links)
• Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms (Q26785930) (← links)
• The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas (Q28190533) (← links)
• Identification of a novel Ras-regulated proapoptotic pathway (Q28203664) (← links)
• Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines (Q28206870) (← links)
• RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1 (Q28215344) (← links)
• RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors (Q28258450) (← links)
• CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer (Q28283044) (← links)
• Fragile histidine triad protein: structure, function, and its association with tumorogenesis. (Q30383886) (← links)
• Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma (Q30781403) (← links)
• The Ras-association domain family (RASSF) members and their role in human tumourigenesis (Q31121564) (← links)
• CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. (Q33213563) (← links)
• RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma (Q33372451) (← links)
• High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer (Q33455585) (← links)
• Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer (Q33535501) (← links)
• Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis (Q33721470) (← links)
• A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression (Q34018955) (← links)
• The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors. (Q34075626) (← links)
• RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1. (Q34271675) (← links)
• DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma (Q34274795) (← links)
• The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. (Q34318060) (← links)
• RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population (Q34323619) (← links)
• DNA methylation, imprinting and cancer (Q34564994) (← links)
• Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma (Q34605107) (← links)
• Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis (Q34606093) (← links)
• A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma (Q34633037) (← links)
• Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver (Q34681945) (← links)
• 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy (Q34770609) (← links)
• Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers (Q34935968) (← links)
• Renal cancer: cytogenetic and molecular genetic aspects (Q34984201) (← links)
• Genetic and epigenetic changes in nasopharyngeal carcinoma. (Q35008876) (← links)
• Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages (Q35153040) (← links)
• Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels (Q35203738) (← links)
• The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician (Q35210967) (← links)
• The genetic basis of renal cell carcinoma (Q35210970) (← links)
• Search for unknown tumor‐antagonizing genes (Q35563102) (← links)
• Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers (Q35593032) (← links)
• Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma. (Q35674241) (← links)
• Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis (Q35856673) (← links)